†Plozasiran (ARO-APOC3), an Investigational RNAi, Demonstrates Robust and Durable TG Reductions in Patients with Mixed Dyslipidemia, MUIR Final Results
医学
血脂异常
药理学
内科学
肥胖
作者
Szilard Vasas,Masoud Azizad,Peter Clifton,Aleesha Shaik,Daniel Gaudet,Jennifer Hellawell,Ting Chang,Stacey Melquist,Ran Fu,Ma’an Mushin,Javier San Martín,Christie M. Ballantyne